Search Results

Genetron Health Presented Its Proprietary Early Screening Technology Mutation Capsule at Science /AAAS Webinar

Genetron Holdings Limited, a China-based precision oncology company that covers full-cycle cancer care, announced that it has joined forces with DARUI.

Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced the company will present at one of the Science/AAAS Webinar Series,

Genetron Health, a China-based precision oncology company that covers full-cycle cancer care, has obtained regulatory approval in China to launch its GENETRON S5 for clinical use.

Genetron Health to Participate at Credit Suisse Asian Investment Conference on Mar. 26 th , 2021

Feb. 13, 2020 15:00 UTC BEIJING--( BUSINESS WIRE )-- Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announced that the National Medical Products Administration (NMPA) has approved its 8-gene Lung Cancer Assay and high-throughput NGS platform GENETRON S2000 to empower comprehensive panel genomic testing for more patients. The 8-gene Lung Cancer Assay is the first lung cancer clinical testing assay bas

Genetron Holdings Limited, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced a strategic partnership with Siemens Healthineers at the China Medical Equipment Fair.

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that its early liver cancer screening research results were cited by the “Chinese Anti-Cancer Association Guidelines for Patients with Primary Liver Cancer”

Genetron Holdings Limited announced that it will release thirteen new research findings at the 21st World Conference on Lung Cancer, which will be held virtually from January 28 to 31.